NEJM August 16, 2025
Therese J. Ziaks, M.S., M.P.H., Jason L. Schwartz, Ph.D., Joseph S. Ross, M.D., M.H.S. https://orcid.org/0000-0002-9218-3320, and Reshma Ramachandran, M.D., M.P.P., M.H.S.

Abstract

The FDA has begun soliciting feedback to inform the next version of the Prescription Drug User...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Pharma, Pharma / Biotech
FDA guidance eases wearables oversight. But experts have questions about what’s next.
AI Model FDA-Cleared to Triage 14 Conditions
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 2)
FDA Updates Two Digital Health Final Guidance Documents
FDA in Flux — January 2026 Newsletter

Share Article